NAPSR News: Johnson & Johnson's Pharma Group Leading the Way

The firm's consumer and medical-device group are lagging, but strong results from the pharmaceuticals side should drive earnings throughout this year and into 2015, says Morningstar's Damien Conover.
Spread the Word
Listed Under

Pharmaceutical Sales


Washington - District of Columbia - US


WASHINGTON - April 17, 2014 - PRLog -- Johnson & Johnson reported strong first-quarter results. The results were ahead both our expectations and consensus expectations. The strength here was really being led by the pharmaceutical group.

When you think about Johnson & Johnson, the three pieces here really the pharmaceutical group is doing very well, while the device group and the consumer group are both lagging. But nevertheless with such power coming from the pharmaceutical group, we are increasing our fair value estimate by $2 to $99 per share. We think that the strength that we've seen in the pharmaceutical group will continue over the next several quarters and will likely have an amplified impact on the bottom line because keep in mind pharmaceutical sales have much higher margins than both the device group and the consumer group.

That should put Johnson & Johnson on a path that should continue to accelerate earnings throughout the remainder of this year and probably into the beginning of next year.

NOW IS THE TIME TO ENTER INTO THIS WONDERFUL FIELD. With such industry leaders posting gains in profitability, they will need both certified and qualified individuals to sell their product. When industry leaders look for new candidates for entry level positions, they look toward individuals that are industry trained. Reason being that they are looking for people that have the background to sell their product both proficiently and efficiently.

CANDIDATES WHO WANT TO BREAK INTO PHARMACEUTICAL SALES!- Upon successful completion of the training each student will receive the Certification Mark of the CNPR®. The CNPR® represents a level of industry achievement and a demonstrated knowledge of pharmacology, medical terminology, pharmaceutical selling guidelines, physician selling techniques and industry standards. Pharmaceutical sales candidates who have this training will differentiate themselves from other individuals looking for open positions. CNPR® graduates should immediately utilize the NAPSRx® Career Center to apply for pharmaceutical sales positions.

The CNPR is a federally trademarked certification you can earn by demonstrating the necessary knowledge in pharmacology, medical terminology, physiology, and regulations for selling pharmaceuticals. The CNPR examination is dedicated to increasing the professional level of NAPSR members and to developing meaningful and ethical standards fully accepted by both its members and members of the pharmaceutical community.

Individuals that are interested in becoming a Certified National Pharmaceutical Representative(CNPR) can contact the National Association of Pharmaceutical Sales Representatives(NAPSRx) for more information.

Email:*** Email Verified
Tags:Napsrx, Cnpr, Pharmaceutical Sales, Certification, Training
Industry:Medical, Science
Location:Washington - District of Columbia - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share